Skip to main content

Eledon Pharmaceuticals, Inc.

ELDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001404281

No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Eledon Pharmaceuticals, Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of ELDN: Q4 2025 compared with Q1 2026
MeasureQ4 2025Of which not filed for Q1 2026Q1 2026Change
Holders951121+27
Shares44.2M4.04M42.6M+2.51M (+6.3%)
Value$66.7M$6.10M$131.2M+$70.6M (+116.6%)

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (42)

Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to ELDN in Q1 2026
InstitutionSharesValue% of portfolio
Vanguard Capital Management LLC3,293,134$10.1M0.00%
Vanguard Fiduciary Trust Co503,764$1.55M0.00%
Vanguard Portfolio Management LLC429,889$1.32M0.00%
BIT Capital GmbH134,000$412.7K0.02%
Deutsche Bank AG89,350$275.2K0.00%
Cambridge Investment Research Advisors, Inc.48,202$148.0K0.00%
MetLife Investment Management42,105$129.7K0.00%
Mitchell & Pahl Private Wealth, LLC30,000$92.4K0.04%
Group One Trading, L.P.29,874$92.0K0.00%
Kestra Private Wealth Services, LLC25,000$77.0K0.00%
Vanguard Global Advisers, LLC22,231$68.5K0.00%
Manufacturers Life Insurance Company, The20,434$62.9K0.00%
Baker Ellis Asset Management LLC19,000$58.5K0.01%
Blair William & Co14,516$44.7K0.00%
Revolve Wealth Partners, LLC14,143$43.6K0.01%
Jones Financial Companies LLLP15,000$42.5K0.00%
Warren Averett Asset Management, LLC12,574$38.7K0.00%
Relyea Zuckerberg Hanson LLC12,000$37.0K0.00%
Prudential Financial Inc10,450$32.2K0.00%
Susquehanna Portfolio Strategies, LLC10,132$31.2K0.00%
Grandfield & Dodd, LLC10,000$30.8K0.00%
Ellis Investment Partners, LLC10,000$30.8K0.01%
Everhart Financial Group, Inc.10,000$30.8K0.00%
SOA Wealth Advisors, LLC.4,566$14.1K0.00%
Navigoe, LLC2,569$7.00K0.00%
GAMMA Investing LLC1,188$3.66K0.00%
Steward Partners Investment Advisory, LLC1,000$3.08K0.00%
Signaturefd, LLC500$1.54K0.00%
IMG Wealth Management, Inc.352$1.08K0.00%
Allworth Financial LP259$7980.00%
MAI Capital Management133$4100.00%
Nisa Investment Advisors, LLC132$4070.00%
Root Financial Partners, LLC110$3390.00%
McGuire Capital Advisors Inc66$2030.00%
SRS Capital Advisors, Inc.23$1570.00%
Farther Finance Advisors, LLC39$1170.00%
Pittenger & Anderson Inc35$1080.00%
True Wealth Design, LLC32$990.00%
Sunbelt Securities, Inc.26$800.00%
IFP Advisors, Inc11$340.00%
SJS Investment Consulting Inc.9$280.00%
Caitong International Asset Management Co., Ltd1$30.00%

Sold out (15)

Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of ELDN in Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Caligan Partners LP555,978$839.5K
Jane Street Group, LLC489,376$739.0K
Colony Group, LLC317,443$479.3K
Boothbay Fund Management, LLC151,569$228.9K
Quadrature Capital Ltd106,014$160.1K
Graham Capital Management, L.P.70,260$106.1K
Marshall Wace, LLP29,547$44.6K
Canada Pension Plan Investment Board29,400$44.4K
Virtu Financial LLC25,920$39.0K
Millennium Management LLC23,788$35.9K
Two Sigma Securities, LLC19,345$29.2K
Tiaa Trust, National Association19,000$28.7K
Mariner, LLC12,414$18.7K
Seven Fleet Capital Management LP6,000$9.06K
Amalgamated Bank1,765$3.00K

Not filed for Q1 2026 yet (1)

Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ELDN in Q4 2025 that haven't filed for Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Vanguard Group Inc4,039,686$6.10M